Calidar Completes First-in-Human Study of Eidos Prism™ and Advances Toward 2027 Pivotal Study

Phase 3Eidos Prism™Positive

AI Analysis

Summary

Calidar announced completion of first-in-human study of Eidos Prism™ and plans to advance toward a pivotal study with five to seven sites across various healthcare settings.

Clinical Trial Data

Phase

Outcome Details

First-in-human study completed; pivotal study advancement announced

Importance:6/10

Sentiment:

0.60

clinical trialfirst-in-humanpivotal studymedical imaging

Related Companies

$CHCT $MDCE $HIT $TRAX

Read the original article

Published by PR Newswire Biotech on August 12, 2026 5:44 PM

Read Original